Citation 1258

CIMANGA,RK:KAMBU,K: TONA,L: HERMANS,N: APERS,S: TOTTE,J: PIETERS,L: VLIETINCK,AJ:. (2006). CYTOTOXICITY AND IN VITRO SUSCEPTIBILITY OF ENTAMOEBA HISTOLYTICA TO MORINDA MORINDOIDES LEAF EXTRACTS AND ITS ISOLATED CONSTITUENTS.. 107(1)

Citation Details

Title	CYTOTOXICITY AND IN VITRO SUSCEPTIBILITY OF ENTAMOEBA HISTOLYTICA TO MORINDA MORINDOIDES LEAF EXTRACTS AND ITS ISOLATED CONSTITUENTS.
Authors	CIMANGA,RK:KAMBU,K: TONA,L: HERMANS,N: APERS,S: TOTTE,J: PIETERS,L: VLIETINCK,AJ:
Year	2006
Volume	107
Issue	1

Summary

Year: 2006

Journal: Unknown

Organisms and Their Experiments (1)

Morinda morindoides (RUBIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	ANTIAMEBIC ACTIVITY	MEDICINAL FOLKLORE REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	None
3	ANTIMALARIAL ACTIVITY	MEDICINAL FOLKLORE REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	None
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	INACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	INACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	INACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	INACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	INACTIVE
9	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	STRONG ACTIVITY
10	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	STRONG ACTIVITY
11	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
12	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	STRONG ACTIVITY
13	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	STRONG ACTIVITY
14	Not specified	ISOLATION AND IDENTIFICATION OF	QUERCETIN	None
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	QUERCETIN	WEAK ACTIVITY
16	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUERCETIN	EQUIVOCAL
17	Not specified	ISOLATION AND IDENTIFICATION OF	QUERCETIN-4'-7-DIMETHYL ETHER	None
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	QUERCETIN-4'-7-DIMETHYL ETHER	WEAK ACTIVITY
19	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUERCETIN-4'-7-DIMETHYL ETHER	WEAK ACTIVITY
20	Not specified	ISOLATION AND IDENTIFICATION OF	RUTIN	None
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RUTIN	INACTIVE
22	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RUTIN	EQUIVOCAL
23	Not specified	ISOLATION AND IDENTIFICATION OF	QUERCITRIN	None
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	QUERCITRIN	INACTIVE
25	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUERCITRIN	EQUIVOCAL
26	Not specified	ISOLATION AND IDENTIFICATION OF	KAEMPFEROL-3-O-RHAMNOSIDE	None
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	KAEMPFEROL-3-O-RHAMNOSIDE	INACTIVE
28	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAEMPFEROL-3-O-RHAMNOSIDE	EQUIVOCAL
29	Not specified	ISOLATION AND IDENTIFICATION OF	NICOTIFLORIN	None
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NICOTIFLORIN	INACTIVE
31	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	NICOTIFLORIN	EQUIVOCAL
32	Not specified	ISOLATION AND IDENTIFICATION OF	KAEMPFEROL-7-O-RHAMNOSYL-SOPHOROSIDE	None
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	KAEMPFEROL-7-O-RHAMNOSYL-SOPHOROSIDE	INACTIVE
34	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAEMPFEROL-7-O-RHAMNOSYL-SOPHOROSIDE	INACTIVE
35	Not specified	ISOLATION AND IDENTIFICATION OF	CHRYSOERIOL-7-O-NEOHESPERIDOSIDE	None
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHRYSOERIOL-7-O-NEOHESPERIDOSIDE	INACTIVE
37	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHRYSOERIOL-7-O-NEOHESPERIDOSIDE	INACTIVE
38	Not specified	ISOLATION AND IDENTIFICATION OF	COSMOSIIN	None
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COSMOSIIN	INACTIVE
40	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	COSMOSIIN	WEAK ACTIVITY
41	Not specified	ISOLATION AND IDENTIFICATION OF	CYNAROSIDE	None
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYNAROSIDE	INACTIVE
43	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CYNAROSIDE	WEAK ACTIVITY
44	Not specified	ISOLATION AND IDENTIFICATION OF	KAEMPFEROL	None
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	KAEMPFEROL	INACTIVE
46	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAEMPFEROL	ACTIVE
47	Not specified	ISOLATION AND IDENTIFICATION OF	APIGENIN	None
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	APIGENIN	INACTIVE
49	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	APIGENIN	ACTIVE
50	Not specified	ISOLATION AND IDENTIFICATION OF	LUTEOLIN	None
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LUTEOLIN	INACTIVE
52	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LUTEOLIN	ACTIVE
53	Not specified	ISOLATION AND IDENTIFICATION OF	GAERTNEROSIDE	None
54	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GAERTNEROSIDE	INACTIVE
55	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GAERTNEROSIDE	STRONG ACTIVITY
56	Not specified	ISOLATION AND IDENTIFICATION OF	GAETNERIC ACID	None
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GAETNERIC ACID	INACTIVE
58	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GAETNERIC ACID	STRONG ACTIVITY
59	Not specified	ISOLATION AND IDENTIFICATION OF	GAERTNEROSIDE,METHOXY:	None
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GAERTNEROSIDE,METHOXY:	INACTIVE
61	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GAERTNEROSIDE,METHOXY:	STRONG ACTIVITY
62	Not specified	ISOLATION AND IDENTIFICATION OF	GAERTNEROSIDE,EPOXY:	None
63	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GAERTNEROSIDE,EPOXY:	INACTIVE
64	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GAERTNEROSIDE,EPOXY:	STRONG ACTIVITY

Citation 1258

Citation Details

Summary

Organisms and Their Experiments (1)

Morinda morindoides (RUBIACEAE)

Show SPARQL Queries (1)

Query 1